Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
書誌事項
- 公開日
- 2019-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/s2352-3026(19)30156-5
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- The Lancet Haematology
-
The Lancet Haematology 6 (12), e630-e637, 2019-12
Elsevier BV
